The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-(2-(Benzo[d][1,3]dioxol-5-yl)ethyl)-4-(2-methoxyphenyl)piperazine ID: ALA2220978
Max Phase: Preclinical
Molecular Formula: C20H24N2O3
Molecular Weight: 340.42
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Synonyms from Alternative Forms(1): LASSBio-772
Canonical SMILES: COc1ccccc1N1CCN(CCc2ccc3c(c2)OCO3)CC1
Standard InChI: InChI=1S/C20H24N2O3/c1-23-18-5-3-2-4-17(18)22-12-10-21(11-13-22)9-8-16-6-7-19-20(14-16)25-15-24-19/h2-7,14H,8-13,15H2,1H3
Standard InChI Key: ZFLJBXISNFUYBH-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 28 0 0 0 0 0 0 0 0999 V2000
-0.1148 -23.0858 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.5941 -22.6632 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.3160 -23.0695 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0228 -22.6505 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0156 -21.8249 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.2954 -21.4200 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.5823 -21.8408 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7220 -21.4056 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4411 -21.8127 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1511 -21.3936 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1433 -20.5675 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4193 -20.1623 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7123 -20.5838 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.2552 -24.3321 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.5385 -23.9187 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.5414 -23.0879 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.2570 -22.6785 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.9704 -23.9192 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.9691 -23.0945 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.7529 -22.8385 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-4.2387 -23.5049 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.7549 -24.1728 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.8282 -22.6725 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4485 -22.6380 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.1670 -23.0442 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12 13 2 0
13 8 1 0
5 8 1 0
5 6 1 0
18 14 1 0
6 7 1 0
14 15 2 0
2 3 1 0
15 16 1 0
16 17 2 0
17 19 1 0
18 19 2 0
8 9 2 0
1 2 1 0
9 10 1 0
2 7 1 0
10 11 2 0
19 20 1 0
20 21 1 0
21 22 1 0
22 18 1 0
3 4 1 0
16 23 1 0
23 1 1 0
11 12 1 0
9 24 1 0
4 5 1 0
24 25 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 340.42Molecular Weight (Monoisotopic): 340.1787AlogP: 2.79#Rotatable Bonds: 5Polar Surface Area: 34.17Molecular Species: NEUTRALHBA: 5HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 7.64CX LogP: 3.41CX LogD: 2.97Aromatic Rings: 2Heavy Atoms: 25QED Weighted: 0.84Np Likeness Score: -0.91
References 1. Silva RO, de Oliveira AS, Nunes Lemes LF, de Camargo Nascente L, Coelho do Nascimento Nogueira P, Silveira ER, Brand GD, Vistoli G, Cilia A, Poggesi E, Buccioni M, Marucci G, Bolognesi ML, Romeiro LAS.. (2016) Synthesis and structure-activity relationships of novel arylpiperazines as potent antagonists of α1-adrenoceptor., 122 [PMID:27448917 ] [10.1016/j.ejmech.2016.06.052 ]